Medical Affairs and Scientific Communications Forum
Medical Communication, MSL, and Medical Writing.
Session 2 Track 2A: Are You Calling Me Transparent? Insights into Clinical Trial Transparency: Layperson Summaries and the Plain Language Initiative
Global Scientific and Regulatory Documentation
Syneos Health, United States
This session discusses the continuously expanding approach to transparency in pharmaceutical development. We will explore the most current breaking developments in the Clinical Trial Transparency space. In addition, we will cover tips for the development of trial summaries using plain language and what patients and healthcare providers want from these summaries.
Deborah E. Collyar
Patient Advocates In Research (PAIR), United States